Key facts
- Cogvis’s last known valuation is $12.0M (Jun 2021).
- It has raised $5.0M; the latest was Later Stage VC in Aug 2025.
- Notable investors include Raiffeisen Landesbank Steiermark, Raiffeisen Beteiligungsholding, TU Wien.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Cogvis
- ·The full record, as it builds
Funding rounds
No funding rounds for Cogvis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cogvis
Developer of a fully privacy-protecting patient monitoring and care assistance system designed to provide patient-centric, autonomous, and high-quality care. The company's artificial intelligence-based system operates directly on a three-dimensional infrared sensor designed for preventing critical care moments related to falls, dementia, and decubitus, and offers mobility tracking and care intensity trends via its reporting platform, enabling nursing professionals to get access to technology and take care of elderly people.
- Sector
- Healthcare
- HQ
- Vienna, Austria
- Founded
- 2007
- Employees
- 28
- Website
- cogvis.ai/
- Ownership
- Privately Held (backing)
Cogvis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cogvis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cogvis in its N-PORT filings yet. We sweep new filings monthly.